Published • loading... • Updated
FDA fills four senior roles, including top officials for drugs, vaccines and tobacco
The moves give the agency permanent leaders for drugs, vaccines and tobacco products and create a new post to oversee artificial intelligence and technology.
- On Tuesday, the administration of President Donald Trump filled four senior positions at the Food and Drug Administration, promoting acting officials to permanent roles following months of high-profile departures.
- Months of upheaval preceded the changes, including departures of Tracy Beth Hoeg, Vinay Prasad, and Marty Makary, who faced scrutiny from industry executives and patient groups over policy shifts.
- New leadership includes Michael Davis at the Center for Drug Evaluation and Research, vaccines center director Karim Mikhail, and Center for Tobacco Products director Bret Koplow.
- Jared Seehafer will serve in a newly created position overseeing artificial intelligence and technology, expanding the agency's regulatory scope into emerging digital health areas.
- Policy shifts continue as Health Secretary Robert emphasizes faster psychedelic reviews, while the agency manages ongoing controversy over COVID-19 vaccine requirements and flavored e-cigarette regulations.
Insights by Ground AI
15 Articles
15 Articles
Associated Press News+14 Reposted by 14 other sources
FDA fills four senior roles, including top officials for drugs, vaccines and tobacco
The Trump administration named four officials to take over senior roles at the Food and Drug Administration, including the agency’s top leaders for drugs and vaccines.
·New York, United States
Read Full ArticleCoverage Details
Total News Sources15
Leaning Left9Leaning Right1Center4Last UpdatedBias Distribution64% Left
Bias Distribution
- 64% of the sources lean Left
64% Left
L 64%
C 29%
Factuality
To view factuality data please Upgrade to Premium
